Cargando…

Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects

BACKGROUND: T cells play an important role in the prognosis of hepatitis B virus (HBV) infection, and are involved in the seroconversion of a patient from HBsAb negative to positive. To compare the T-cell receptor β-chain variable region (TcRBV) complementarity-determining region 3 (CDR3) in subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Dangsheng, Wang, Ju, Chen, Zhitao, Jin, Xiuyuan, Xie, Yirui, Yan, Dong, Yang, Jiezuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825183/
https://www.ncbi.nlm.nih.gov/pubmed/33485302
http://dx.doi.org/10.1186/s12879-021-05816-2
_version_ 1783640249213124608
author Xiao, Dangsheng
Wang, Ju
Chen, Zhitao
Jin, Xiuyuan
Xie, Yirui
Yan, Dong
Yang, Jiezuan
author_facet Xiao, Dangsheng
Wang, Ju
Chen, Zhitao
Jin, Xiuyuan
Xie, Yirui
Yan, Dong
Yang, Jiezuan
author_sort Xiao, Dangsheng
collection PubMed
description BACKGROUND: T cells play an important role in the prognosis of hepatitis B virus (HBV) infection, and are involved in the seroconversion of a patient from HBsAb negative to positive. To compare the T-cell receptor β-chain variable region (TcRBV) complementarity-determining region 3 (CDR3) in subjects with or without hepatitis B surface antigen (HBsAg) convert to hepatitis B surface antibody (HBsAb), the TcRBV was determined using high throughput sequencing (HTS). METHODS: The clonotype and diversity of CDR3 in peripheral blood mononuclear cells of subjects with resolved acute hepatitis B (AHB, HBsAb+, HBsAg-) (n = 5), chronic hepatitis B (CHB, HBsAb-, HBsAg+) (n = 5), and healthy controls (HC, HBsAb-, HBsAg-) (n = 3) were determined and analyzed using HTS (MiSeq). RESULTS: The overlapping rate of CDR3 clones of any two samples in AHB group was 2.00% (1.74% ~ 2.30%), CHB group was 1.77% (1.43% ~ 2.61%), and HC group was 1.82% (1.62% ~ 2.12%), and there was no significant difference among the three groups by Kruskal-Wallis H test. However, among the top 10 cumulative frequencies of clonotypes, only the frequency of clonotype (TcRBV20–1/BD1/BJ1–2) in AHB group was lower than that of HC group (P < 0.001). Moreover, exclude the 10 top clonotypes, there are 57 markedly different frequency of clones between AHB and CHB groups (18 clones up, 39 clones down), 179 (180–1) different clones between AHB and HC groups, and 134 different clones between CHB and HC groups. With regard to BV and BJ genotypes, there was no significant different frequency among the groups. Furthermore, there was no significant difference in the diversity of TcRBV CDR3 among the three groups (P > 0.05). CONCLUSIONS: Thus, there are 57 TcRBV clonotypes that may be related to HBsAg seroconversion of AHB subjects, but the diversity of TcRBV CDR3 is not significantly related to the HBsAb positive status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-05816-2.
format Online
Article
Text
id pubmed-7825183
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78251832021-01-25 Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects Xiao, Dangsheng Wang, Ju Chen, Zhitao Jin, Xiuyuan Xie, Yirui Yan, Dong Yang, Jiezuan BMC Infect Dis Research Article BACKGROUND: T cells play an important role in the prognosis of hepatitis B virus (HBV) infection, and are involved in the seroconversion of a patient from HBsAb negative to positive. To compare the T-cell receptor β-chain variable region (TcRBV) complementarity-determining region 3 (CDR3) in subjects with or without hepatitis B surface antigen (HBsAg) convert to hepatitis B surface antibody (HBsAb), the TcRBV was determined using high throughput sequencing (HTS). METHODS: The clonotype and diversity of CDR3 in peripheral blood mononuclear cells of subjects with resolved acute hepatitis B (AHB, HBsAb+, HBsAg-) (n = 5), chronic hepatitis B (CHB, HBsAb-, HBsAg+) (n = 5), and healthy controls (HC, HBsAb-, HBsAg-) (n = 3) were determined and analyzed using HTS (MiSeq). RESULTS: The overlapping rate of CDR3 clones of any two samples in AHB group was 2.00% (1.74% ~ 2.30%), CHB group was 1.77% (1.43% ~ 2.61%), and HC group was 1.82% (1.62% ~ 2.12%), and there was no significant difference among the three groups by Kruskal-Wallis H test. However, among the top 10 cumulative frequencies of clonotypes, only the frequency of clonotype (TcRBV20–1/BD1/BJ1–2) in AHB group was lower than that of HC group (P < 0.001). Moreover, exclude the 10 top clonotypes, there are 57 markedly different frequency of clones between AHB and CHB groups (18 clones up, 39 clones down), 179 (180–1) different clones between AHB and HC groups, and 134 different clones between CHB and HC groups. With regard to BV and BJ genotypes, there was no significant different frequency among the groups. Furthermore, there was no significant difference in the diversity of TcRBV CDR3 among the three groups (P > 0.05). CONCLUSIONS: Thus, there are 57 TcRBV clonotypes that may be related to HBsAg seroconversion of AHB subjects, but the diversity of TcRBV CDR3 is not significantly related to the HBsAb positive status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-05816-2. BioMed Central 2021-01-23 /pmc/articles/PMC7825183/ /pubmed/33485302 http://dx.doi.org/10.1186/s12879-021-05816-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Xiao, Dangsheng
Wang, Ju
Chen, Zhitao
Jin, Xiuyuan
Xie, Yirui
Yan, Dong
Yang, Jiezuan
Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects
title Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects
title_full Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects
title_fullStr Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects
title_full_unstemmed Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects
title_short Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects
title_sort restricted tcr β chain cdr3 clonotype is associated with resolved acute hepatitis b subjects
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825183/
https://www.ncbi.nlm.nih.gov/pubmed/33485302
http://dx.doi.org/10.1186/s12879-021-05816-2
work_keys_str_mv AT xiaodangsheng restrictedtcrbchaincdr3clonotypeisassociatedwithresolvedacutehepatitisbsubjects
AT wangju restrictedtcrbchaincdr3clonotypeisassociatedwithresolvedacutehepatitisbsubjects
AT chenzhitao restrictedtcrbchaincdr3clonotypeisassociatedwithresolvedacutehepatitisbsubjects
AT jinxiuyuan restrictedtcrbchaincdr3clonotypeisassociatedwithresolvedacutehepatitisbsubjects
AT xieyirui restrictedtcrbchaincdr3clonotypeisassociatedwithresolvedacutehepatitisbsubjects
AT yandong restrictedtcrbchaincdr3clonotypeisassociatedwithresolvedacutehepatitisbsubjects
AT yangjiezuan restrictedtcrbchaincdr3clonotypeisassociatedwithresolvedacutehepatitisbsubjects